Multiplex Networks and Pan-Cancer Multiomics-Based Driver Gene Identification Using Graph Neural Networks

Identifying cancer driver genes has paramount significance in elucidating the intricate mechanisms underlying cancer development, progression, and therapeutic interventions. Abundant omics data and interactome networks provided by numerous extensive databases enable the application of graph deep lea...

Full description

Saved in:
Bibliographic Details
Main Authors: Xingyi Li, Junming Li, Jun Hao, Xingyu Liao, Min Li, Xuequn Shang
Format: Article
Language:English
Published: Tsinghua University Press 2024-12-01
Series:Big Data Mining and Analytics
Subjects:
Online Access:https://www.sciopen.com/article/10.26599/BDMA.2024.9020043
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Identifying cancer driver genes has paramount significance in elucidating the intricate mechanisms underlying cancer development, progression, and therapeutic interventions. Abundant omics data and interactome networks provided by numerous extensive databases enable the application of graph deep learning techniques that incorporate network structures into the deep learning framework. However, most existing models primarily focus on individual network, inevitably neglecting the incompleteness and noise of interactions. Moreover, samples with imbalanced classes in driver gene identification hamper the performance of models. To address this, we propose a novel deep learning framework MMGN, which integrates multiplex networks and pan-cancer multiomics data using graph neural networks combined with negative sample inference to discover cancer driver genes, which not only enhances gene feature learning based on the mutual information and the consensus regularizer, but also achieves balanced class of positive and negative samples for model training. The reliability of MMGN has been verified by the Area Under the Receiver Operating Characteristic curves (AUROC) and the Area Under the Precision-Recall Curves (AUPRC). We believe MMGN has the potential to provide new prospects in precision oncology and may find broader applications in predicting biomarkers for other intricate diseases. Implementations of MMGN can be found at https://github.com/xingyili/MMGN.
ISSN:2096-0654